Utility of the detection of Plasmodium parasites for the diagnosis of malaria in endemic areas by Perneger, Thomas V et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
BMC Infectious Diseases
Open Access Research article
Utility of the detection of Plasmodium parasites for the diagnosis of 
malaria in endemic areas
Thomas V Perneger*1,2, Thomas Szeless1 and André Rougemont1
Address: 1Institute of Social and Preventive Medicine, University of Geneva, CH-1211 Geneva, Switzerland and 2Quality of Care Service, University 
Hospitals of Geneva, CH-1211 Geneva, Switzerland
Email: Thomas V Perneger* - thomas.perneger@hcuge.ch; Thomas Szeless - tszeless_gr@sec.sec.spital.ktso.ch; 
André Rougemont - andre.rougemont@imsp.unige.ch
* Corresponding author    
Abstract
Background: In populations where the prevalence of infection with Plasmodium parasites is high,
blood tests that identify Plasmodium parasites in patients with fever may lead to false positive
diagnosis of malaria-disease. We characterised the diminishing value of the parasite detection test
as a function of the prevalence of infection.
Methods: We computed the ability of the parasite detection test to identify malaria at various
levels of prevalence (0% to 90%), assuming plausible estimates of sensitivity (95% and 85%) and
specificity (99% and 95%) for the detection of parasites. In each situation, we computed likelihood
ratios of malaria (or absence of malaria) for positive and negative parasite detection tests.
Likelihood ratios were classified as clinically useful (≥ 10), intermediate (5–10), or unhelpful (<5).
Results: Likelihood ratios of positive tests were strongly related to the prevalence of infection in
the general population: a positive test was unhelpful when the prevalence was 20% or more, and
useful only when prevalence was 5% or less. The sensitivity and specificity of the test had little
influence on these results. Likelihood ratios of negative tests were clinically useful when prevalence
was 70% or less, but only for high levels of sensitivity (95%). If sensitivity was low (85%), the
negative test was at best of intermediate utility, and was unhelpful if the prevalence of asymptomatic
infection exceeded 30%.
Conclusion: Identification of Plasmodium parasites supports a diagnosis of malaria only in areas
where the prevalence of Plasmodium infection is low. Wherever this prevalence exceeds about 20%,
a positive test is clinically unhelpful.
Background
In current practice, the diagnosis of malaria in a patient in
whom this disease is suspected rests on the identification
of Plasmodium parasites in the patient's blood [1]. This
diagnostic method is currently recommended by the
World Health Organization [2]. Parasite detection tests
include the classical methods of the thick or thin blood
smear, and various rapid diagnostic tests [3].
This approach works well in cases of traveller's malaria,
and more generally whenever the patient is unlikely to be
an asymptomatic carrier of Plasmodium parasites. How-
ever, in populations where malaria is common, many
Published: 02 May 2006
BMC Infectious Diseases 2006, 6:81 doi:10.1186/1471-2334-6-81
Received: 08 February 2006
Accepted: 02 May 2006
This article is available from: http://www.biomedcentral.com/1471-2334/6/81
© 2006 Perneger et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Infectious Diseases 2006, 6:81 http://www.biomedcentral.com/1471-2334/6/81
Page 2 of 7
(page number not for citation purposes)
people are infected by Plasmodium parasites without
being sick. In such situations, using the presence of para-
sites as a criterion for diagnosing malaria in a febrile
patient will lead to over-diagnosis of malaria, unnecessary
anti-malarial treatments, and missed diagnoses of other
febrile illnesses. While this point has been made by
experts previously [1], it is usually framed in general
terms, without precise guidance as to when a positive or a
negative parasite detection test is clinically useful, and
when it is not. In this paper, we examine the influence of
the prevalence of asymptomatic parasitic infection on the
clinical utility of parasite detection for the diagnosis of
malaria in patients with fever.
Methods
We examined various hypotheses regarding test perform-
ance and the prevalence of parasitic infection in the gen-
eral population. A prevalence <20% is sometimes
qualified as low, 20–50% as intermediate, and >50% as
high.
We distinguish between the ability of a test to detect par-
asites in a person's blood, i.e., infection, from its ability to
identify malaria as clinical disease in a patient with fever.
The former is a general characteristic of the test, independ-
ent of the prevalence of parasitic infection. The latter per-
tains to a test used in specific epidemiologic
circumstances, and is related to the prevalence of infection
(Box 1).
Assessing the utility of a diagnostic test
Classic measures of the performance of a diagnostic test
are its sensitivity (Sn) – i.e., the proportion of positive
tests among those with the disease – and its specificity
(Sp) – i.e., the proportion of negative tests among those
without the disease. However, these statistics are not
directly applicable in clinical practice, for if we knew who
had the disease and who did not, we would not need the
test. The clinician is typically interested in the test's posi-
tive predictive value – i.e., the proportion of diseased peo-
ple among those with a positive test, and in its negative
predictive value – i.e., the proportion of non-diseased
people among those with a negative test. The drawback of
these statistics is that they depend strongly on the pre-test
probability of disease, which varies from patient to
patient.
The statistic that best characterises the clinical utility of a
test result is the likelihood ratio (LR) [5-7]. The likelihood
ratio is the ratio of probabilities of a given test result under
the 2 hypotheses under consideration – i.e., presence ver-
sus absence of disease. The likelihood ratio of a positive
test is given by LR+ = Sn/(1 - Sp), and the likelihood ratio
of a negative test, by LR- = (1 - Sn)/Sp. To facilitate com-
parisons [6,7], likelihood ratios of a negative test are
sometimes shown for the absence of disease, i.e., LR-0 = Sp/
(1 - Sn). This merely inverses the likelihood ratio: a likeli-
hood ratio of 0.1 for the disease becomes 10 for the
absence of disease. We have adopted this convention in
this paper.
The likelihood ratio allows the computation of the post-
test probability of disease. According to the Bayes' theo-
rem, post-test odds of disease are the product of the like-
lihood ratio and the pre-test odds [5-7]. Because
probabilities can be converted into odds (O = P/(1 - P)),
and odds into probabilities (P = O/(O + 1)), the likeli-
hood ratio allows the transformation of a pre-test proba-
bility into a post-test probability (Figure 1). For example,
if the pre-test probability of disease was 20% (i.e., pre-test
odds = 1/4), and the test was positive, with a likelihood
ratio of 8, the post-test odds of disease would be 2 (i.e., 8
× (1/4)), and the corresponding probability 66.7% (i.e.,
2/(2+1)).
This is how likelihood ratios can be interpreted [6]: a like-
lihood ratio is clinically useful if it equals 10 or more, of
intermediate usefulness between 5 and 10, and clinically
unhelpful below 5.
Detection of parasites in blood
To examine the performance of a parasite detection test
for determining the presence or absence of Plasmodium
parasites in the blood, we assumed a sensitivity of either
85% or 95%, and a specificity of either 95% or 99%. This
Post-test probability of malaria, as a function of pre-test  probability of malaria, for 5 levels of the likelihood ratio of a  positive test (2, 5, 10, 20 or 50) Figure 1
Post-test probability of malaria, as a function of pre-test 
probability of malaria, for 5 levels of the likelihood ratio of a 
positive test (2, 5, 10, 20 or 50). An uninformative test (likeli-
hood ratio = 1) is shown as a diagonal dotted line.BMC Infectious Diseases 2006, 6:81 http://www.biomedcentral.com/1471-2334/6/81
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means that among 100 persons who harbour parasites,
the test will be positive for 85 or 95. The remaining are
"false negatives", due to technical problems, or to the par-
asite being absent from peripheral blood for a portion of
its life cycle [4]. Similarly, among 100 persons who do not
harbour parasites, the test will be falsely positive for 1 to
5, due to various laboratory errors. These values of sensi-
tivity and specificity can be considered as realistic in a well
equipped and expertly managed laboratory.
Diagnosis of malaria
In a clinical context, the purpose of the test is not merely
to detect parasites in the blood, but to establish or rule out
the diagnosis of malaria in patients in whom the disease
is suspected. Three types of patients should be considered
(Table 1): a) patients with malaria, all of whom can be
assumed to harbour parasites, b) patients with fever from
another origin who are also infected – but not ill – with
Plasmodium, and c) patients with fever from another ori-
gin who are not infected with Plasmodium. The probability
that patients with fever from another origin are also
infected with Plasmodium equals roughly the prevalence of
parasitic infection in the general population. If this preva-
lence is nil, as is the case in much of the Western world,
the performance of the test for diagnosing malaria is the
same as for identifying the presence of parasites.
The sensitivity of the parasite detection test for detecting
malaria (Snm) will be the same as its sensitivity for detect-
ing parasites (Snp). However, the specificity of the test for
detecting malaria (Spm) will be influenced by the preva-
lence of infection, because the population under consid-
eration is a mixture of two subgroups: patients who are
infected with Plasmodium  (proportion x), and of those
who are not (proportion 1-x). The specificity of the test for
detecting malaria becomes Spm = Spp·(1 - x) + (1 - Snp)·x,
and its complement, 1 - Spm = (1 - Spp)·(1 - x) + Snp·x
(Box 1).
Consequently, the likelihood ratio of a positive test for the
presence of malaria disease becomes
. The likelihood ratio
of a negative test for the absence  of malaria is
.
Note that the proportion of Plasmodium carriage in the
population (denoted by x in Table 1) is distinct from the
pre-test probability of malaria in a given patient with fever
(denoted by m in Table 1). The former is a characteristic
of the population to which the patient belongs. The latter
depends on various patient-related factors, such as the
intensity and temporal pattern of fever, presence or
absence of an enlarged spleen, anemia, pregnancy, age,
exposure to mosquito bites, season, likelihood of alter-
nate diseases, etc.
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Table 1: Performance of Plasmodium detection tests in endemic populations: a) detection of the presence of parasites, b) diagnosis of a 
malaria. The parameters considered include the specificity of the test for the detection of parasites in blood (Snp), the corresponding 
specificity (Spp), the prevalence of malaria infection in the general population (x), and the pre-test probability of a malaria attack in a 
patient with fever (m)
a) Detection of parasites
Disease status
Malaria Other febrile illness, parasites 
present
Other febrile illness, parasites 
absent
Positive parasite detection test Snp Snp 1-Spp
Negative parasite detection test 1-Snp 1-Snp Spp
Column totals 1 1 1
Prevalence of infection in the 
general population
-x 1 - x
b) Detection of malaria (disease)
Malaria Other febrile illness
Positive parasite detection test Snp Snp·x + (1-Spp)·(1-x)
Negative parasite detection test 1-Snp (1-Snp)·x + Spp·(1-x)
Column totals 1 1
Pre-test probability of malaria m 1-mBMC Infectious Diseases 2006, 6:81 http://www.biomedcentral.com/1471-2334/6/81
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Effect of a higher threshold for a positive test
Thus far we have assumed that the test would perform
equally well in patients who suffer from malaria and in
those who are infected but not ill with malaria. But
because parasite levels are likely higher in the former
group, the test may discriminate better if a higher parasite
threshold is used to diagnose malaria – say, greater than
1000 parasites per µL instead of greater than 0. Raising the
diagnostic threshold will decrease the sensitivity of the
test, but less so in patients with malaria (Snp-malaria) than
in other patients (Snp-other). At the same time, raising the
threshold will increase the specificity of the test to virtu-
ally 100%. Under these conditions, the likelihood ratio of
a positive test for the presence of malaria becomes:
, and the likelihood ratio of a
negative test for the absence of malaria becomes
.
Analysis of test performance
We considered a range of prevalence of infection in the
general population between 0% and 90%, and plausible
values of sensitivity (0.85 and 0.95) and specificity (0.95
and 0.99) of the test for the detection of parasites. We
show likelihood ratios of malaria for a positive test (Table
2), and of absence of malaria for a negative test (Table 3).
We also explored the effect of raising the diagnostic
threshold, assuming that this will lower the sensitivity of
the test, but less so in patients with malaria than in
patients with an asymptomatic infection (Table 4). The
computations were done using macro functions written
for SPSS software.
Results
Detection of parasites
The likelihood ratios for the detection of parasites corre-
spond to those of the detection of malaria when the prev-
alence of asymptomatic infection is assumed to be nil
(first result lines in Tables 2 and 3). For a positive test, the
likelihood ratio was very high (95 and 85) when specifi-
city was modelled as 0.99, and is still clinically useful (at
19 and 17) when specificity was assumed to be 0.95
(Table 2). In contrast, the likelihood ratio of a negative
test depended on the value of sensitivity: it was close to 20
when sensitivity was modelled as 0.95, but of only border-
line utility, around 6, when sensitivity was entered as 0.85
(Table 3).
Detection of malaria
Likelihood ratios of malaria for a positive test varied con-
siderably with the prevalence of Plasmodium infection
(Table 2). When the prevalence was assumed to be 5% or
less, the likelihood ratios were about 10 or more, in the
clinically useful range. On the other hand, for a preva-
lence of 20% or more, the likelihood ratio dropped below
5, which would not be considered clinically useful. At low
values of prevalence, the specificity of the test influenced
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Table 2: Likelihood ratios of malaria when the parasite detection test is positive, according to the prevalence of infection in the general 
population, and to the sensitivity and specificity of the test for the detection of parasites. Clinically useful tests are in bolded type, tests 
of intermediate utility are in standard type, clinically unhelpful tests in italics
Prevalence of infection in 
the general population
Sensitivity = 0.95 Sensitivity = 0.85
Spec. = 0.99 Spec. = 0.95 Spec. = 0.99 Spec. = 0.95
0% 95.0 19.0 85.0 17.0
0.1% 86.8 18.7 78.4 16.7
1% 49.0 16.1 46.2 14.7
2% 33.0 14.0 31.7 12.9
5% 16.7 10.0 16.4 9.4
10% 9.1 6.8 9.0 6.5
15% 6.3 5.1 6.2 5.0
20% 4 . 84 . 14 . 84 . 0
30% 3 . 23 . 03 . 23 . 0
40% 2 . 52 . 32 . 52 . 3
50% 2 . 01 . 92 . 01 . 9
60% 1 . 71 . 61 . 61 . 6
70% 1 . 41 . 41 . 41 . 4
80% 1 . 21 . 21 . 21 . 2
90% 1 . 11 . 11 . 11 . 1BMC Infectious Diseases 2006, 6:81 http://www.biomedcentral.com/1471-2334/6/81
Page 5 of 7
(page number not for citation purposes)
considerably test performance. Whether sensitivity was
modelled as 0.85 or as 0.95 was of little import for the
likelihood ratios.
The impact of the prevalence of infection on the useful-
ness of a negative test was also notable (Table 3). The neg-
ative test remained clinically useful up to a prevalence of
about 50%, as long as the sensitivity was high (0.95).
However, even a negative test was not clinically useful
when the prevalence exceeded 70%, or if the sensitivity of
the test was assumed to be 0.85.
Impact of a higher threshold for a positive test
Likelihood ratios of presence of malaria for a positive test
improved when the diagnostic threshold was increased. If
the change of threshold decreased sensitivity to 0.80 in
patients with malaria and to 0.60 in patients with asymp-
tomatic infection, a positive test was clinically useful up to
Table 3: Likelihood ratios of the absence of malaria when the parasite detection test is negative, according to the prevalence of 
infection in the general population, and to the sensitivity and specificity of the test for the detection of parasites. Clinically useful tests 
are in bolded type, tests of intermediate utility are in standard type, clinically unhelpful tests in italics
Prevalence of infection in 
the general population
Sensitivity = 0.95 Sensitivity = 0.85
Spec. = 0.99 Spec. = 0.95 Spec. = 0.99 Spec. = 0.95
0% 19.8 19.0 6.6 6.3
0.1% 19.8 19.0 6.6 6.3
1% 19.6 18.8 6.5 6.2
2% 19.4 18.6 6.5 6.2
5% 18.9 18.1 6.3 6.1
10% 17.9 17.2 6.0 5.8
15% 17.0 16.3 5.8 5.5
20% 16.0 15.4 5.5 5.3
30% 14.2 13.6 4.9 4.7
40% 12.3 11.8 4.7 4.2
50% 10.4 10.0 3.8 3.7
60% 8.5 8.2 3.2 3.1
70% 6.6 6.4 2.7 2.6
80% 4 . 84 . 62 . 12 . 1
90% 2 . 92 . 81 . 61 . 5
Table 4: Likelihood ratios of positive test for presence of malaria if a high threshold is used to define a positive test. The sensitivity of 
the test is reduced, but less so for patients with malaria than for other infected individuals, and specificity is considered to be perfect 
(100%). Clinically useful tests are in bolded type, tests of intermediate utility are in standard type, clinically unhelpful tests in italics
Prevalence of infection in the general 
population
Sensitivity of test in patients with malaria: 0.80. Sensitivity of test in other infected patients:
0.60 0.40
0% infinite infinite
0.1% 1333 2000
1% 133 200
2% 67.7 100
5% 26.7 40.0
10% 13.3 20.0
15% 8.9 13.3
20% 6.7 10
30% 4.4 6.7
40% 3.3 5.0
50% 2.7 4.0
60% 2.2 3.3
70% 1.9 2.9
80% 1.7 2.5
90% 1.5 2.2BMC Infectious Diseases 2006, 6:81 http://www.biomedcentral.com/1471-2334/6/81
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a prevalence of infection of 10% (Table 4). If the sensitiv-
ities were 0.80 and 0.40, the test became useful up to a
prevalence of 20%. In contrast, such a change of threshold
virtually abolished the utility of a negative test. Even in the
best case scenario (prevalence of 0%), the likelihood ratio
of a negative test for absence of malaria was 5, and it was
less than 5 in all other situations (detailed results not
shown).
Discussion
Globally, this analysis confirms that a positive parasite
detection test is unhelpful in establishing the diagnosis of
malaria in highly endemic areas [1], and defines a range
of situations where a negative test is useful in excluding
the diagnosis. Even in areas of intermediate prevalence of
infection in the general population (20%–50%), a posi-
tive test for Plasmodium parasites in the blood does not
establish the diagnosis of malaria. In such situations, the
likelihood ratio is 5 or less, which will push the post-test
probability of malaria above 90% only if the pre-test
probability was already very high, greater than 70%. In
highly endemic areas (>50%), a positive test is virtually
meaningless, with likelihood ratios <2. While the general
direction of these results is unsurprising, our study pro-
vides for the first time a definition of circumstances in
which a parasite detection test is or is not useful for the
diagnosis of malaria.
Positive parasite detection test
The likelihood ratio of a positive test depends strongly on
the prevalence of infection in the general population, and
is hardly influenced by the sensitivity or specificity of the
test, within the range we considered. In fact, the formula
for the likelihood ratio of a positive test (LR(+)m) implies
that this ratio cannot exceed the inverse of the prevalence
of infection (or 1/x), even if both sensitivity and specifi-
city for the detection of parasites are a perfect 100%. For
example, if half of the population is infected by Plasmo-
dium parasites, the likelihood ratio cannot exceed 2. Con-
sequently, if prevalence of infection is high, ruling in
malaria cannot be improved much by the development of
more sensitive parasite detection tests, such as those based
on the polymerase chain reaction assays [9]. Therefore a
positive Plasmodium detection test has little utility in pop-
ulations where malaria is most frequent, as in Africa,
where most of the burden of mortality and morbidity of
malaria occurs [10].
Using a higher parasite density threshold to consider a test
as positive may improve the value of a positive test [11].
This is because raising the threshold will reduce the sensi-
tivity among patients who harbour parasites but do not
have clinical malaria more than among patients with
malaria. However, even this strategy will not extend the
usefulness of the positive test beyond a prevalence of
asymptomatic infection greater than 20%. Furthermore,
this strategy will invalidate the utility of a negative para-
site detection test.
Negative parasite detection test
In contrast, the diagnostic contribution of the negative test
varied considerably with the sensitivity of the test. When
sensitivity was deemed equal to 0.95, the negative test
produced high, clinically useful likelihood ratios up to a
prevalence of infection of 70%, allowing the exclusion of
malaria even in populations where Plasmodium infection
is highly prevalent. On the other hand, when sensitivity
was assumed to be only 0.85, the likelihood ratios of a
negative test were lower, and exceeded 5 only up to a prev-
alence of asymptomatic infection of about 20%. Therefore
the sensitivity of the Plasmodium detection test is critical
for ruling out malaria in highly endemic populations.
Ruling out malaria in patients with fever is important, to
avoid unnecessary treatment with antimalarial drugs,
which is common in highly endemic countries [1], and to
provide appropriate etiologic treatment to the patients
[12]. In this paper, we do not address the issue of malaria
control at the population level, which may or may not
include the treatment of asymptomatic carriers.
Good quality laboratory tests to rule out Plasmodium
infection are therefore important, especially in highly
endemic areas. Our estimates assumed rather high values
of sensitivity and specificity of the parasite detection test.
In precarious field conditions, these test properties may be
worse [13,14]. Lower sensitivity would considerably
reduce the clinical usefulness of a negative test. Unfortu-
nately, given the insufficient quality of many field labora-
tories, the practical contribution of a Plasmodium
detection test to the diagnosis of malaria is often limited
[15].
Improving the diagnosis of malaria
Establishing the diagnosis of clinical malaria in endemic
areas remains a challenge. As mentioned before, detection
of  Plasmodium infection in a patient presenting with a
febrile acute illness is not a sufficient basis for the diagno-
sis. A useful contribution would be the identification of
parameters, whether clinical variables or laboratory meas-
urements, that distinguish patients who suffer from
malaria from patients who have another febrile illness
and merely harbour Plasmodium parasites. If clinical algo-
rithms that yield a high enough pre-test probability of
malaria were available, even a positive Plasmodium detec-
tion test associated with a modest likelihood ratio would
help establish the diagnosis.
Several clinical algorithms have been proposed [16-20],
but none seems sufficiently accurate as a basis for the diag-
nosis. A key difficulty in developing good diagnostic algo-BMC Infectious Diseases 2006, 6:81 http://www.biomedcentral.com/1471-2334/6/81
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rithms is the lack of a gold standard for diagnosing
malaria. One cannot aim at a target that remains invisible.
Development of adequate technologies to diagnose
malaria in endemic areas remains an important and diffi-
cult public health challenge.
The difficulty in establishing the diagnosis of malaria
increases with the prevalence of infection. It is noteworthy
that reliance on positive Plasmodium detection tests
remains justified in patients whose probability of asymp-
tomatic parasitic infection is low, such as among travellers
[14]. More generally, the issue of malaria diagnosis
explored in this paper illustrates the difficulty in transfer-
ring a technological solution that is well suited to the
developed world to other contexts.
Conclusion
In populations where the prevalence of Plasmodium infec-
tion is intermediate or high, a positive Plasmodium detec-
tion test does not help establish the diagnosis of malaria.
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